Arena Pharmaceuticals, Inc. Proceeds from Issuance Initial Public Offering
Arena Pharmaceuticals, Inc. reported Proceeds from Issuance Initial Public Offering of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2022-02-23
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for the quarter ending 2021-09-30 was $0.00.
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for the quarter ending 2020-12-31 was $70.00K.
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for the quarter ending 2020-09-30 was -$5.00K.
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2020 was $301.82M.
- Arena Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $0.00 derived: sum of 2 quarters · filed 2022-02-23 | $0.00 10-K · filed 2022-02-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $65.00K derived: sum of 2 quarters · filed 2022-02-23 | $301.82M 10-K · filed 2022-02-23 | |
| 2020-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $301.75M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $301.75M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-23 |